Dubai-based hybrid digital therapeutics company GluCare.Health, says it is collaborating with the Middle East’s largest self-drive mobility firm, ekar, “to provide the most convenient access to diabetes screening technology.”
Starting from Sunday, 13 November and running until the 21 Novemeber Glu.Care will provide all ekar customers with free screening tests at its clinic, including those for HbA1C, Blood Pressure, and BMI.
These tests will provide data and results which can accurately help empower individuals with their own personal journey in combatting or treating diabetes, the healthcare company explained.
Appointments can be scheduled via the clinic’s website and by presenting the confirmation email upon arrival. ekar users will also be gifted 15 minutes of free driving to the clinic using its geotargeting technology.
GluCare.Health is a UAE-founded world-leading metabolic disease management platform, currently producing vastly better patient outcomes than comparable solutions. It uses data from various medical devices and wearables as part of its standard continuous care model shifting diabetes management away from archaic fragmented and episodic care to a continuous and behavioral-change-based approach.
“A little-known fact is that every private health insurance plan, regardless of tier, is required by law to include regular basic metabolic screening for the entire covered population. When we catch prediabetes early, the progression of metabolic disease can be not only stopped, it can be reversed. We cannot over-emphasize the importance of widespread metabolic screening, best driven by employers themselves. To have two Polymath portfolio companies partner together in order to drive both awareness and access to metabolic screening is a privilege,” said Ali Hashemi, Managing Director of Polymath Ventures and Chairman of GluCare.Health and ekar.
GluCare.Health believes that healthcare systems should adopt major changes in the way they practice diabetes management and this care should be accessible to everyone.
“The return on investment in regular screening is exponential, we hope to continue to raise awareness in the community as part of our commitment to corporate social responsibility,” concludes Hashemi.
GluCare.Health will also be hosting its regular free-to-attend Type 1 in-clinic Support Group on November 24th. Both Support Groups are facilitated by a GluCare.Health coach where group participation is encouraged and the topics covered stem from the thoughts and questions of the individuals attending. GluCare.Health will also, throughout the month, be working with educational institutes, businesses and independents to raise awareness about diabetes as part of the company’s commitment to CSR initiatives.
